Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

A quality process study of lymph node evaluation in endometrial cancer.

Forde GK, Carlson JW, Downey GO, Doss BJ, Shoemaker A, Harrison CR.

Int J Gynecol Pathol. 2011 Jul;30(4):335-9. doi: 10.1097/PGP.0b013e31820dc39d. Review.

PMID:
21623200
2.

Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.

Hiura M, Nogawa T, Matsumoto T, Yokoyama T, Shiroyama Y, Wroblewski J.

Int J Gynecol Cancer. 2010 Aug;20(6):1000-5. doi: 10.1111/IGC.0b013e3181d80aff.

PMID:
20683408
3.

A retrospective analysis of the diameter of metastatic lymph nodes in apparently early stage endometrial cancer.

Boran N, Akdag D, Halici F, Tulunay G, Turan T, Bozok S, Erdogan Z, Kose MF.

Tumori. 2008 Sep-Oct;94(5):681-5.

4.

Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes.

Chuang L, Burke TW, Tornos C, Marino BD, Mitchell MF, Tortolero-Luna G, Levenback C, Morris M, Gershenson DM.

Gynecol Oncol. 1995 Aug;58(2):189-93.

PMID:
7622103
5.

The impact of surgical guidelines and periodic quality assessment on the staging of endometrial cancer.

Bakkum-Gamez JN, Mariani A, Dowdy SC, Weaver AL, McGree ME, Cliby WA, Gostout BS, Stanhope CR, Wilson TO, Podratz KC.

Gynecol Oncol. 2011 Oct;123(1):58-64. doi: 10.1016/j.ygyno.2011.06.018. Epub 2011 Jul 13.

PMID:
21741696
6.

Can we omit para-aorta lymph node dissection in endometrial cancer?

Tanaka H, Sato H, Miura H, Sato N, Fujimoto T, Konishi Y, Takahashi O, Tanaka T.

Jpn J Clin Oncol. 2006 Sep;36(9):578-81. Epub 2006 Jul 26.

PMID:
16870694
7.

Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.

Lutman CV, Havrilesky LJ, Cragun JM, Secord AA, Calingaert B, Berchuck A, Clarke-Pearson DL, Soper JT.

Gynecol Oncol. 2006 Jul;102(1):92-7. Epub 2006 Jan 10.

PMID:
16406063
8.

Lymph node counts in endometrial cancer: expectations versus reality.

Euscher ED, Bassett R, Malpica A.

Am J Surg Pathol. 2011 Jun;35(6):913-8. doi: 10.1097/PAS.0b013e31821899be.

PMID:
21566518
9.
10.

Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status.

Fotopoulou C, Savvatis K, Kraetschell R, Schefold JC, Lichtenegger W, Sehouli J.

Eur J Obstet Gynecol Reprod Biol. 2010 Apr;149(2):199-203. doi: 10.1016/j.ejogrb.2009.12.021. Epub 2010 Jan 22.

PMID:
20096987
11.

The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.

Chi DS, Barakat RR, Palayekar MJ, Levine DA, Sonoda Y, Alektiar K, Brown CL, Abu-Rustum NR.

Int J Gynecol Cancer. 2008 Mar-Apr;18(2):269-73. doi: 10.1111/j.1525-1438.2007.00996.x.

PMID:
18334008
12.

[Clinical analysis on the lymph nodes metastasis characters and their relation with the prognosis of the endometrial carcinoma patients].

Wang ZQ, Zhang Y, Wang JL, Shen DH, Zhao X, Yao YY, Bai Y, Wei LH.

Zhonghua Fu Chan Ke Za Zhi. 2011 Jun;46(6):435-40. Chinese.

PMID:
21781585
13.

Factors influencing the number of pelvic and para-aortic lymph nodes removed in surgical treatment of endometrial and ovarian cancer.

Hareyama H, Ito K, Watanabe S, Hakoyama M, Uchida A, Oku K, Watanabe Y, Hayakashi Y, Hirayama E, Okuyama K.

Int J Gynecol Cancer. 2012 Nov;22(9):1577-84. doi: 10.1097/IGC.0b013e31826fd644.

PMID:
23060049
14.

Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma.

Mohan DS, Samuels MA, Selim MA, Shalodi AD, Ellis RJ, Samuels JR, Yun HJ.

Gynecol Oncol. 1998 Aug;70(2):165-71.

PMID:
9740684
15.

Lymph node counts in uterine cancer: a randomized double blind trial.

Santoso JT, Azadi A, Wan J, Handorf C, Coleman RL, Tillmanns TD.

Gynecol Oncol. 2009 May;113(2):159-62. doi: 10.1016/j.ygyno.2009.02.001. Epub 2009 Mar 5.

PMID:
19268343
16.
17.

Comparison of outcomes and cost for endometrial cancer staging via traditional laparotomy, standard laparoscopy and robotic techniques.

Bell MC, Torgerson J, Seshadri-Kreaden U, Suttle AW, Hunt S.

Gynecol Oncol. 2008 Dec;111(3):407-11. doi: 10.1016/j.ygyno.2008.08.022. Epub 2008 Oct 1.

PMID:
18829091
18.

Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients.

Mariani A, Dowdy SC, Cliby WA, Haddock MG, Keeney GL, Lesnick TG, Podratz KC.

Gynecol Oncol. 2006 May;101(2):200-8. Epub 2006 Feb 28.

PMID:
16510174
19.

Ultrastaging of para-aortic lymph nodes in stage IIIC1 endometrial cancer: a preliminary report.

Todo Y, Suzuki Y, Azuma M, Hatanaka Y, Konno Y, Watari H, Kato H, Matsuno Y, Yamashiro K, Sakuragi N.

Gynecol Oncol. 2012 Dec;127(3):532-7. doi: 10.1016/j.ygyno.2012.08.026. Epub 2012 Aug 30.

PMID:
22940490
20.

Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, Angioli R, Tateo S, Mangili G, Katsaros D, Garozzo G, Campagnutta E, Donadello N, Greggi S, Melpignano M, Raspagliesi F, Ragni N, Cormio G, Grassi R, Franchi M, Giannarelli D, Fossati R, Torri V, Amoroso M, Crocè C, Mangioni C.

J Natl Cancer Inst. 2008 Dec 3;100(23):1707-16. doi: 10.1093/jnci/djn397. Epub 2008 Nov 25.

PMID:
19033573

Supplemental Content

Support Center